ÂÜÀòÂÒÂ×

Oskar Slotboom joined BioGeneration Ventures as a partner in 2016, strengthening the team with his commercial, business development and consulting experience. Oskar started his career in McKinsey & Company as a management consultant. After that he held positions in Crucell, first as Business Development Director and later he became responsible for its pediatric franchise. After the acquisition of Crucell by Johnson & Johnson, Oskar led the Vaccines & Infectious Diseases business unit in Johnson & Johnson’s pharma joint venture, Xian Janssen, in Beijing, China. Oskar holds a degree in chemical engineering from the Twente University and holds an MBA from INSEAD.